Literature DB >> 6171709

Essential Role of T cells in the postexposure prophylaxis of rabies in mice.

K Mifune, E Takeuchi, P A Napiorkowski, A Yamada, K Sakamoto.   

Abstract

Athymic nude mice injected intramuscularly with a street stain of rabies virus were not protected against rabies by postexposure administration of beta-propiolactone-inactivated rabies vaccine. In contrast, their normal littermates were completely protected from death by the same vaccination regimens. Nude mice did not produce IgG antibody as a result of the vaccine during the test period of 15 days, whereas normal littermates produced IgG antibody from day 5 after vaccination. However, passive immunization with antirabies hyperimmune mouse ascites showed that antibody was completely ineffective in protecting either nude mice or their normal littermates against rabies when given later than 2 days after infection. No significant difference in the induction of circulating interferon by the vaccination was noted in these mice. Passive transfer of immune spleen cells to nude mice immediately after infection resulted in 30 to 37.5% protection of the mice. Passively transferred spleen cells did not produce detectable amounts of neutralizing antibody in the recipient mice except on day 2 after the transfer, when a low level of antibody was detected. These observations demonstrate the essential role of T cells in the postexposure prophylaxis of rabies in mice. The mechanisms of the failure of postexposure vaccination in nude mice are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171709     DOI: 10.1111/j.1348-0421.1981.tb00094.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice.

Authors:  J W Templeton; C Holmberg; T Garber; R M Sharp
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

2.  Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.

Authors:  J H Nunberg; M V Doyle; S M York; C J York
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Immune sera and antiglycoprotein monoclonal antibodies inhibit in vitro cell-to-cell spread of pathogenic rabies viruses.

Authors:  D L Lodmell; L C Ewalt
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection.

Authors:  Corin L Dorfmeier; Andrew G Lytle; Amber L Dunkel; Anthony Gatt; James P McGettigan
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

5.  Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein.

Authors:  M Fekadu; J W Sumner; J H Shaddock; D W Sanderlin; G M Baer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination.

Authors:  M Herzog; C Fritzell; M Lafage; J A Montaño Hirose; D Scott-Algara; M Lafon
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

7.  Reinvestigating the role of IgM in rabies virus postexposure vaccination.

Authors:  Corin L Dorfmeier; Shixue Shen; Evgeni P Tzvetkov; James P McGettigan
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

8.  B cell infection and activation by rabies virus-based vaccines.

Authors:  Andrew G Lytle; James E Norton; Corin L Dorfmeier; Shixue Shen; James P McGettigan
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

9.  Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice.

Authors:  D L Lodmell; L C Ewalt
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Investigating the role for IL-21 in rabies virus vaccine-induced immunity.

Authors:  Corin L Dorfmeier; Evgeni P Tzvetkov; Anthony Gatt; James P McGettigan
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.